Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.
- DOI
- 10.1186/s12943-025-02226-9
- Published
- 2025 Feb 15
- Container
- Molecular cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-025-02226-9,
title = {Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.},
author = {Luo L and Yang P and Mastoraki S and Rao X and Wang Y and Kettner NM and Raghavendra AS and Tripathy D and Damodaran S and Hunt KK and Wang J and Li Z and Keyomarsi K},
year = {2025},
journal = {Molecular cancer},
doi = {10.1186/s12943-025-02226-9},
url = {https://doi.org/10.1186/s12943-025-02226-9}
}RIS
TY - JOUR TI - Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer. AU - Luo L AU - Yang P AU - Mastoraki S AU - Rao X AU - Wang Y AU - Kettner NM AU - Raghavendra AS AU - Tripathy D AU - Damodaran S AU - Hunt KK AU - Wang J AU - Li Z AU - Keyomarsi K PY - 2025 JO - Molecular cancer DO - 10.1186/s12943-025-02226-9 UR - https://doi.org/10.1186/s12943-025-02226-9 ER -
APA
L, L., P, Y., S, M., X, R., Y, W., NM, K., AS, R., D, T., S, D., KK, H., J, W., Z, L., & K, K. (2025). Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.. Molecular cancer. https://doi.org/10.1186/s12943-025-02226-9
Source records
- pubmed · retrieved 2026-09-25T21:48:39.885Z